Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00029172 · ClinicalTrials.gov registry record · Phase 4
Treatment for Post-Stroke Depression
A Phase 4 study, sponsored by Indiana University.
- Completed
- Registry status
- Phase 4
- Development phase
- 188
- Enrollment target
NCT00029172: Completed Phase 4 study, sponsored by Indiana University.
NCT00029172 is a Phase 4 study that has completed, run by Indiana University. The registered enrollment target is 188 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (64% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00029172, a Phase 4 study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 188 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate a program of education, medicine, and monitoring for the treatment of depression after a stroke.
Primary Outcome
Depression remission was defined as HAM-D less than 8 or HAM-D decreased by 50%. The Hamilton Rating Scale for Depression is measured on a scale from no depression - major depression, 0-52 units on a scale.
Interventions
- OTHER case management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 188 participants |
| Start Date | 1999-05 |
| Est. Completion | 2005-12 |
| Phase | Phase 4 |
What the finished NCT00029172 record still lists
NCT00029172 is an interventional study that assigns participants to a tested intervention. The registered 188 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (64% lower).
The record links to 0 conditions, and to 1 intervention - of which case management is the first listed.
NCT00029172 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00029172 about?
NCT00029172 is a clinical study titled "Treatment for Post-Stroke Depression". The purpose of this study is to evaluate a program of education, medicine, and monitoring for the treatment of depression after a stroke.
What is the current status of trial NCT00029172?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 188 participants. The study started on 1999-05. Estimated completion is 2005-12.
What interventions are being tested in trial NCT00029172?
The interventions under investigation include: case management (OTHER).
Who is sponsoring clinical trial NCT00029172?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00029172's enrollment target sits among peer trials
188 456th of 2000 higher than 1,542 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03422198 · 188 participants · Phase 3
Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer
- NCT04469790 · 188 participants · NA
Effects of Multi-day Interruptions in Sitting on Type 2 Diabetes-relevant Outcomes in Children
- NCT04671667 · 188 participants · Phase 2
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
- NCT04853251 · 188 participants · Phase 4
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia